Roivant Sciences Price Pattern Analysis
| ROIV Stock | USD 28.82 0.50 1.77% |
Momentum
OversoldOverbought
56 · Buy Extended
Headline intensity for Roivant Sciences alongside corresponding price behavior reveals sentiment conviction. Peer-level hype data provides context for interpreting Roivant Sciences' attention signals.
Roivant Sciences Current Signal Summary
Roivant Sciences's momentum reading (RSI at 56) sits in neutral territory, while the expected daily return of 0.2% is positive and hype elasticity is slightly positive. Daily volatility at 2.19% is moderate, suggesting a standard range of near-term outcomes. Moderate headline density (13 events/month) reflects steady media coverage. Overall, momentum, expected return, and sentiment signals are aligned in a constructive direction for Roivant Sciences.
News and social attention around Roivant Sciences help frame whether recent price moves are sentiment-driven. Headline and social attention alongside volatility data help frame near-term price expectations.
Roivant Sciences Post-Event Predicted Price | $ 28.83 |
Attention context alongside forecasting, technical signals, and analyst estimates adds depth. Earnings views and momentum indicators complement sentiment signals.
The mean reversion principle applied to Roivant Sciences' suggests that neither prolonged outperformance nor underperformance is permanent. Identifying the root cause of Roivant Sciences' price dislocation is essential before acting on a mean reversion signal. The mean reversion tendency in Roivant Sciences' price is a well-documented phenomenon in academic research. In many cases, Roivant Sciences' price extremes present statistical patterns that have recurred historically.
Post-Sentiment Price Density Analysis
Roivant Sciences's return distribution captures the full spectrum of possible outcomes, including tail events. The tails of the Roivant Sciences distribution capture low-probability but high-impact outcomes that point estimates ignore. Any model claiming to eliminate forecasting uncertainty for Roivant Sciences overstates its accuracy. Probability distribution analysis is most useful for Roivant Sciences when combined with fundamental context and sentiment data.
Next price density |
| Expected price to next headline |
Estimated Post-Sentiment Price Volatility
The projected after-hype price range for Roivant Sciences is derived from Roivant Sciences' historical news coverage and market behavior. Roivant Sciences' post-sentiment downside and upside margins for the prediction period are 26.64 and 31.02, respectively. These boundaries reflect how Roivant Sciences has historically moved in response to comparable catalysts.
Current Value
The after-hype framework applied to Roivant Sciences assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. Roivant Sciences is Very Low at this time.
Price Outlook Analysis
When Roivant Sciences' Stock price moves apart from earnings, non-data drivers such as fund flows and sentiment often explain the gap. Sentiment often acts as momentum, and if good press slows, the Stock price loses steam.
| Expected Return | Period Volatility | Sentiment Sensitivity | Peer Sensitivity | News Density | Peer Density | Next Expected Sentiment |
0.20 | 2.19 | 0.01 | 0.93 | 13 Events | 8 Events | In 13 days |
| Latest Traded Price | Expected Post-Event Price | Potential Return on Next Event | Post-Sentiment Volatility | |
28.82 | 28.83 | 0.03 |
|
Market Sentiment Timeline
Roivant Sciences is at this time traded for 28.82. Roivant Sciences has a historical sentiment sensitivity of 0.01. Peers average a sentiment sensitivity of -0.93. is forecasted to increase in value after the next headline, with the post-event price near 28.83 or above. The average volatility of media hype impact on ROIV the price is over 100%. The price increase on the next news is projected to be 0.03%, whereas the daily expected return is at this time at 0.2%. The volatility of peer sentiment impact on Roivant Sciences is about 47.05%, with the expected peer-implied price after the next announcement near 27.89. ROIV reported previous year's revenue of $29.05 million. Net Loss for the year was -$356.73 million with loss before overhead, payroll, taxes, and interest of -$614.67 million. Given a 90-day horizon, the next forecasted press release will be in 13 days. Roivant Sciences Basic Forecasting Models add a structured statistical layer to the projection analysis for Roivant Sciences.Exploring Roivant Sciences Stock for the first time? Start with our How to Buy Roivant Sciences Stock step-by-step guide. It provides a clear overview of how to add Roivant Sciences to your portfolio. It is a useful companion to the data and analysis available for Roivant Sciences Stock.Related Market Sentiment Analysis
Analyzing Roivant Sciences' peer sentiment data reveals which competitors are most likely to influence Roivant Sciences's short-term price. Sentiment elasticity, information ratio, and semi-deviation help contextualize the relative news sensitivity of Roivant Sciences. The peer sentiment summary table for Roivant Sciences serves as a competitive intelligence tool for Roivant Sciences' sector. Cross-referencing Roivant Sciences' peer reactions with Roivant Sciences's own news response reveals the degree of sector correlation.
| SentimentElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SMMT | Summit Therapeutics PLC | 0.03 | 17 per month | 5.52 | 0.1 | 8.23 | -6.67 | 40.56 | |
| BBIO | BridgeBio Pharma | -0.10 | 25 per month | 2.33 | 0.04 | 6.23 | -3.97 | 19.68 | |
| RVMD | Revolution Medicines | -0.10 | 25 per month | 1.69 | 0.14 | 6.04 | -3.79 | 46.32 | |
| ASND | Ascendis Pharma AS | 0.03 | 22 per month | 1.97 | 0.06 | 4.42 | -3.25 | 9.84 | |
| IONS | Ionis Pharmaceuticals | -0.32 | 3 per month | 0.00 | -0.09 | 3.54 | -3.28 | 9.02 | |
| EXAS | EXACT Sciences | -0.10 | 24 per month | 0.00 | 0.14 | 1.45 | -0.68 | 1,002 | |
| RNA | Atrium Therapeutics Common | -0.21 | 10 per month | 0.00 | -0.14 | 5.10 | -6.47 | 79.85 | |
| RPRX | Royalty Pharma Plc | 0.68 | 11 per month | 0.87 | 0.22 | 2.73 | -1.40 | 6.42 | |
| JAZZ | Jazz Pharmaceuticals PLC | 0.03 | 26 per month | 1.14 | 0.22 | 2.94 | -2.68 | 17.22 | |
| MRNA | Moderna | -46.49 | 23 per month | 2.83 | 0.09 | 6.08 | -4.95 | 23.48 |
Roivant Sciences Additional Predictive Modules
Forecasting Roivant Sciences's price movement relies on structured analysis of indicator behavior, momentum signatures, and historical volatility patterns. Predictive accuracy varies by market regime - trending markets and range-bound markets favor different model types.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sentiment Indicators & Methodology
Sentiment analysis for Roivant Sciences evaluates news tone, positioning, and narrative momentum. Narrative alignment can reinforce trend persistence in certain regimes. Roivant Sciences has a market cap of 20.3 billion, ROE of -19.14%.
Roivant Sciences metrics draw on periodic company reporting and market reference feeds, standardized for cross-period comparison.
Editorial review and methodology oversight provided by: Michael Smolkin, Member of Macroaxis Board of Directors
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Roivant Sciences Stock Analysis
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market.Share PortfolioTrack or share privately all of your investments from the convenience of any devicePositions RatingsView algorithmic ratings for individual portfolio positions based on fundamental analysis and risk-adjusted market performanceTop Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchangesFundamental AnalysisView fundamental data based on most recent published financial statementsContent SyndicationQuickly integrate customizable finance content to your own investment portalPortfolio HoldingsCheck your current holdings and cash position to determine if your portfolio needs rebalancingGlobal Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexesPrice Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets